|
Sign In to gain access to subscriptions and/or personal tools.
|
Oral and Parenteral Glutamine in Bone Marrow Transplantation: A Randomized, Double-Blind Study
Paul R. Schloerb, MD
Department of Surgery, Division of Hematology and Bone Marrow Transplantation, University of Kansas Medical Center, Kansas City
Barry S. Skikne, MD
Department of Medicine, Division of Hematology and Bone Marrow Transplantation, University of Kansas Medical Center, Kansas City
Background: Total parenteral nutrition (TPN) supplemented with glutamine (GLN) has been reported to be effective for patients with bone marrow transplantation (BMT). Our aim was to evaluate enteral and parenteral glutamine in patients undergoing BMT. Methods: For evaluation of GLN in BMT, 66 patients with 43 hematologic and 23 solid malignancies (21 breast carcinomas), were randomized, double-blinded, to either oral GLN (n = 35) or glycine-control (GLY) (n = 31), 10 g three times daily. When TPN became necessary, patients who received GLN orally were given TPN with GLN (0.57 g/kg). Those who received GLY received standard TPN, isocaloric and isonitrogenous. Patients with hematologic malignancies received high-dose chemotherapy, total body irradiation, and either allogeneic (ALLO) BMT (n = 18) or autologous (AUTO) stem cell transplantation (n = 25). Patients with solid malignancies (n = 23) received AUTO. Results: There were 14 in-hospital deaths without relationship to GLN administration. For respective comparisons of ALLO and AUTO transplants in the GLN and GLY hematologic groups and AUTO in the solid tumor groups, there were no significant differences in hospital stay, duration of stay after BMT, TPN days, neutrophil recovery >500/mm 3, incidence of positive blood cultures, sepsis, mucositis, and diarrhea. Acute graft us host disease occurred in 1 of 10 hematologic patients receiving GLN and in 3 of 8 patients receiving GLY placebo (p > .05). Possible reduction in need for TPN and a suggestion of improved long-term survival were associated with GLN. Conclusions: Oral and parenteral GLN seemed to be of limited benefit for patients having AUTO or ALLO BMT for hematologic or solid malignancies. Further study of long-term effects of GLN in BMT seems warranted. (Journal of Parenteral and Enteral Nutrition 23:117-122, 1999)
Journal of Parenteral and Enteral Nutrition, Vol. 23, No. 3,
117-122 (1999)
DOI: 10.1177/0148607199023003117
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
D. A. August, M. B. Huhmann, and the American Society for Parenteral and Enteral Nu
A.S.P.E.N. Clinical Guidelines: Nutrition Support Therapy During Adult Anticancer Treatment and in Hematopoietic Cell Transplantation
JPEN J Parenter Enteral Nutr,
September 1, 2009;
33(5):
472 - 500.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. F. Estivariz, D. P. Griffith, M. Luo, E. E. Szeszycki, N. Bazargan, N. Dave, N. M. Daignault, G. F. Bergman, T. McNally, C. H. Battey, et al.
Efficacy of Parenteral Nutrition Supplemented With Glutamine Dipeptide to Decrease Hospital Infections in Critically Ill Surgical Patients
JPEN J Parenter Enteral Nutr,
July 1, 2008;
32(4):
389 - 402.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Xue, M. B. Sawyer, C. J. Field, L. A. Dieleman, D. Murray, and V. E. Baracos
Bolus Oral Glutamine Protects Rats against CPT-11-Induced Diarrhea and Differentially Activates Cytoprotective Mechanisms in Host Intestine but Not Tumor
J. Nutr.,
April 1, 2008;
138(4):
740 - 746.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Storey
The Role of Oral Glutamine in Pediatric Bone Marrow Transplant
Journal of Pediatric Oncology Nursing,
January 1, 2007;
24(1):
41 - 45.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Richardson, L. Martel, and L. Martensson
Outpatient Transfusion Practice and Factors Leading to Inpatient Transfusion in a Pediatric Hematology/Oncology Program
Journal of Pediatric Oncology Nursing,
January 1, 2007;
24(1):
46 - 51.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Barrera
Nutritional Support in Cancer Patients
JPEN J Parenter Enteral Nutr,
September 1, 2002;
26(5_suppl):
S63 - S71.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. S. Scolapio, V. B. Tarrosa, G. L. Stoner, A. Moreno-Aspitia, L. A. Solberg Jr, and E. J. Atkinson
Audit of Nutrition Support for Hematopoietic Stem Cell Transplantation at a Single Institution
Mayo Clin. Proc.,
July 1, 2002;
77(7):
654 - 659.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. Duggan, J. Gannon, and W A. Walker
Protective nutrients and functional foods for the gastrointestinal tract
Am. J. Clinical Nutrition,
May 1, 2002;
75(5):
789 - 808.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Muscaritoli, G. Grieco, S. Capria, A. Paola Iori, and F. Rossi Fanelli
Nutritional and metabolic support in patients undergoing bone marrow transplantation
Am. J. Clinical Nutrition,
February 1, 2002;
75(2):
183 - 190.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
American Society for Parenteral and Enteral Nutrit
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
JPEN J Parenter Enteral Nutr,
January 1, 2002;
26(1_suppl):
1SA - 138SA.
[PDF]
|
|
|
|
|
|
|
P. Newsholme
Why Is L-Glutamine Metabolism Important to Cells of the Immune System in Health, Postinjury, Surgery or Infection?
J. Nutr.,
September 1, 2001;
131(9):
2515S - 2522.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Boelens, R. J. Nijveldt, A. P. J. Houdijk, S. Meijer, and P. A. M. van Leeuwen
Glutamine Alimentation in Catabolic State
J. Nutr.,
September 1, 2001;
131(9):
2569S - 2577.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. R. Ziegler
Glutamine Supplementation in Cancer Patients Receiving Bone Marrow Transplantation and High Dose Chemotherapy
J. Nutr.,
September 1, 2001;
131(9):
2578S - 2584.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L Buchman
Glutamine: commercially essential or conditionally essential? A critical appraisal of the human data
Am. J. Clinical Nutrition,
July 1, 2001;
74(1):
25 - 32.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Lenssen, B. Bruemmer, S. N. Aker, and G. B. McDonald
Nutrient Support in Hematopoietic Cell Transplantation
JPEN J Parenter Enteral Nutr,
July 1, 2001;
25(4):
219 - 228.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. R. Schloerb
Immune-Enhancing Diets: Products, Components, and Their Rationales
JPEN J Parenter Enteral Nutr,
March 1, 2001;
25(2_suppl):
S3 - S7.
[PDF]
|
|
|
|
|
|
|
T. R. Ziegler, C. F. Estivariz, C. R. Jonas, L. H. Gu, D. P. Jones, and L. M. Leader
Interactions Between Nutrients and Peptide Growth Factors in Intestinal Growth, Repair, and Function
JPEN J Parenter Enteral Nutr,
November 1, 1999;
23(6_suppl):
S174 - S183.
[Abstract]
[PDF]
|
|
|
|
|
